J Clin Endocrinol Metab (2016) 101(5):193544.10.1210/jc.2015-2583 167 JansenPLvan WervenJAartsEBerendsFJanssenIStokerJet alAlterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery
Novo Nordisk stated that neither clinical trials nor post-marketing data suggest a reasonable possibility that semaglutide causes NAION
It is written from the perspective of board-certified Emergency Medicine physicians who manage weight-loss medications inside a real, longitudinal practice, not a one-visit telehealth funnel
However, combining these medicines requires careful clinical consideration and individualised riskbenefit assessment by a prescribing clinician
As our understanding of GLP-1-associated skin changes continues to evolve, treatment strategies are likely to focus not only on replacing lost volume but also on restoring the biological processes that maintain healthy, youthful skin
But since type 1 diabetes isnt connected to obesity, the demand for Insulet products probably wont change much